Clinical Trial

Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides

Study acronym: PFESWTCP
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 8, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-11-16; most recent amendment 2025-12-02.
Trial Details
NCT Number NCT06138236
Lead Sponsor Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Conditions Plantar Fascitis
Enrollment 84 participants
Start Date 2023-07-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-08